×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
NYSE:MPW

Medical Properties Trust Price Target, Predictions & Analyst Ratings

$15.64
+0.37 (+2.42%)
(As of 07/1/2022 03:59 PM ET)
Add
Compare
Today's Range
$15.17
$15.70
50-Day Range
$14.34
$18.96
52-Week Range
$14.10
$24.13
Volume
442,693 shs
Average Volume
8.96 million shs
Market Capitalization
$9.39 billion
P/E Ratio
8.36
Dividend Yield
7.42%
Price Target
$22.00

Medical Properties Trust (NYSE:MPW) Price Target and Consensus Rating (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 9 Analyst Ratings

Consensus Analyst Price Target

$22.00
40.66% Upside
High Prediction$26.00
Average Prediction$22.00
Low Prediction$15.00
TypeCurrent
7/5/21 to 7/5/22
1 Month Ago
6/5/21 to 6/5/22
3 Months Ago
4/6/21 to 4/6/22
1 Year Ago
7/5/20 to 7/5/21
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
6 Buy rating(s)
Hold
5 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$22.00$23.11$24.13$23.44
Predicted Upside40.66% Upside10.48% Upside12.92% Upside14.05% Upside
Get Medical Properties Trust Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MPW and its competitors with MarketBeat's FREE daily newsletter.


MPW Stock Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MPW Stock Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Medical Properties Trust Stock vs. The Competition

TypeMedical Properties TrustFinance CompaniesS&P 500
Consensus Rating Score
2.56
2.52
2.51
Consensus RatingModerate BuyBuyBuy
Predicted Upside40.66% Upside71.14% Upside31.66% Upside
News Sentiment RatingPositive News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
402
61.56%
Underperform Votes
251
38.44%
Avg. Outperform Votes
151
62.66%
Avg. Underperform Votes
90
37.34%
Avg. Outperform Votes
839
69.11%
Avg. Underperform Votes
375
30.89%

Historical Medical Properties Trust Price Targets and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/30/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$19.00 ➝ $15.00-4.94%
6/22/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral$24.00 ➝ $18.00+22.78%
4/27/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Derek Johnston
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Target$25.00 ➝ $20.00+10.38%
3/24/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$26.00 ➝ $23.00+13.81%
3/11/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$21.00+1.89%
2/14/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$27.00 ➝ $26.00+19.98%
1/20/2022Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$23.00 ➝ $26.00+11.44%
10/29/2021Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy$25.00 ➝ $26.00+20.15%
8/11/2021Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSector Perform ➝ Outperform$23.00+16.63%
6/14/2021Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoveragePeer Perform$23.00+4.69%
2/8/2021Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$23.00 ➝ $25.00+14.26%
1/21/2021KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$22.00 ➝ $24.00+8.99%
9/9/2020Colliers Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Bauser
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$23.00+26.30%
9/1/2020Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$21.00+13.21%
6/25/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$19.00 ➝ $20.00+9.65%
4/3/2020Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$21.00 ➝ $16.00+11.97%
1/14/2020Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$20.00 ➝ $22.00+2.18%
9/12/2019Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$22.00+17.46%
(Data available from 7/5/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












Medical Properties Trust Price Target - Frequently Asked Questions

What is Medical Properties Trust's consensus rating and price target?

According to the issued ratings of 9 analysts in the last year, the consensus rating for Medical Properties Trust stock is Moderate Buy based on the current 5 hold ratings, 3 buy ratings and 1 strong buy rating for MPW. The average twelve-month price prediction for Medical Properties Trust is $22.00 with a high price target of $26.00 and a low price target of $15.00. Learn more on MPW's analyst rating history.

Do Wall Street analysts like Medical Properties Trust more than its competitors?

Analysts like Medical Properties Trust stock more than the stock of other Finance companies. The consensus rating for Medical Properties Trust is Moderate Buy while the average consensus rating for finance companies is Buy. Learn more on how MPW compares to other companies.

Do MarketBeat users like Medical Properties Trust more than its competitors?

MarketBeat users like Medical Properties Trust stock less than the stock of other Finance companies. 61.56% of MarketBeat users gave Medical Properties Trust an outperform vote while finance companies recieve an average of 62.76% outperform votes by MarketBeat users.

Is Medical Properties Trust being downgraded by Wall Street analysts?

Over the previous 90 days, Medical Properties Trust's stock had 2 downgrades by analysts.

Does Medical Properties Trust's stock price have much upside?

According to analysts, Medical Properties Trust's stock has a predicted upside of 11.90% based on their 12-month price targets.

What analysts cover Medical Properties Trust?

Medical Properties Trust has been rated by Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, and JPMorgan Chase & Co. in the past 90 days.

This page (NYSE:MPW) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.